CHICAGO, Dec 18 (Reuters) - An investor sued Abbott Laboratories (ABT.N: Quote, Profile, Research) for halting development of the ZoMaxx stent, saying the healthcare company breached an obligation when it dropped the product.
CHICAGO, Dec 18 (Reuters) - An investor sued Abbott Laboratories (ABT.N: Quote, Profile, Research) for halting development of the ZoMaxx stent, saying the healthcare company breached an obligation when it dropped the product.
